The familial occurrence may give a clue to the pathogenesis of inclusion body myositis

Intern Med. 2003 Oct;42(10):928-9.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Adrenal Cortex Hormones
  • Anti-Inflammatory Agents / therapeutic use
  • Genetic Predisposition to Disease
  • Humans
  • Myositis, Inclusion Body / drug therapy
  • Myositis, Inclusion Body / genetics*
  • Myositis, Inclusion Body / immunology*

Substances

  • Adrenal Cortex Hormones
  • Anti-Inflammatory Agents